583 related articles for article (PubMed ID: 12783488)
1. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
[TBL] [Abstract][Full Text] [Related]
2. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
[TBL] [Abstract][Full Text] [Related]
3. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors.
Kunkel JP; Jan DC; Butler M; Jamieson JC
Biotechnol Prog; 2000; 16(3):462-70. PubMed ID: 10835250
[TBL] [Abstract][Full Text] [Related]
5. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
[TBL] [Abstract][Full Text] [Related]
6. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
Ozturk SS; Palsson BO
Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
[TBL] [Abstract][Full Text] [Related]
7. Continuous production of monoclonal antibody in a packed-bed bioreactor.
Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
[TBL] [Abstract][Full Text] [Related]
8. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
[TBL] [Abstract][Full Text] [Related]
9. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
10. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2.
Majid FA; Butler M; Al-Rubeai M
Biotechnol Bioeng; 2007 May; 97(1):156-69. PubMed ID: 17013932
[TBL] [Abstract][Full Text] [Related]
12. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
Dong H; Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
Kundu PK; Prasad NS; Datta D
Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
[TBL] [Abstract][Full Text] [Related]
14. Production of monoclonal antibodies in culture.
Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
[TBL] [Abstract][Full Text] [Related]
15. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
Cherlet M; Marc A
Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
[TBL] [Abstract][Full Text] [Related]
17. Serum preparation and methods for the large-scale production of IgG monoclonal antibody.
Zeng QS; Takeyama H; Kanda S; Irie RF
Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185
[TBL] [Abstract][Full Text] [Related]
18. Getting higher yields of monoclonal antibody in culture.
Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
[TBL] [Abstract][Full Text] [Related]
19. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures.
Serrato JA; Palomares LA; Meneses-Acosta A; Ramírez OT
Biotechnol Bioeng; 2004 Oct; 88(2):176-88. PubMed ID: 15449295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]